OTIC failed a phase 3 trial and fell from $20 to $5, and hasn’t recovered since despite succeeding in another phase 3.
Otonomy And Its Efforts At Resurrecting Itself (NASDAQ:OTIC)
1970-01-01T00:00:00-05:00January 1st, 1970|
Related Posts
-
Dow Closes Above 40,000 For First Time
May 17th, 2024